Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009
Published online before print October 29, 2009, doi: 10.1161/CIRCRESAHA.108.183400
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Burstein, B.
Right arrow Articles by Nattel, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burstein, B.
Right arrow Articles by Nattel, S.
Related Collections
Right arrow Other heart failure
Right arrow Arrythmias-basic studies
Right arrow Arrhythmias, clinical electrophysiology, drugs

Submitted on July 16, 2008
Revised on October 14, 2009
Accepted on October 15, 2009

Changes in Connexin Expression and the Atrial Fibrillation Substrate in Congestive Heart Failure

Brett Burstein ; Philippe Comtois ; Georghia Michael ; Kunihiro Nishida ; Louis Villeneuve ; Yung-Hsin Yeh ; and Stanley Nattel *

From the Department of Medicine (B.B., G.M., K.N., L.V., Y.-H.Y., S.N.) and Physiology/Institute of Biomedical Engineering (P.C.), Research Center (B.B., P.C., G.M., K.N., Y.-H.Y., S.N.), Montreal Heart Institute and Université de Montréal; and Department of Pharmacology and Therapeutics (B.B., S.N.), McGill University.

* To whom correspondence should be addressed. E-mail: stanley.nattel{at}icm-mhi.org.

Rationale: Although connexin changes are important for the ventricular arrhythmic substrate in congestive heart failure (CHF), connexin alterations during CHF-related atrial arrhythmogenic remodeling have received limited attention.

Objective: To analyze connexin changes and their potential contribution to the atrial fibrillation (AF) substrate during the development and reversal of CHF.

Methods and Results: Three groups of dogs were studied: CHF induced by 2-week ventricular tachypacing (240 bpm, n=15); CHF dogs allowed a 4-week nonpaced recovery interval after 2-week tachypacing (n=16); and nonpaced sham controls (n=19). Left ventricular (LV) end-diastolic pressure and atrial refractory periods increased with CHF and normalized on CHF recovery. CHF caused abnormalities in atrial conduction indices and increased the duration of burst pacing-induced AF (DAF, from 22±7 seconds in control to 1100±171 seconds, P<0.001). CHF did not significantly alter overall atrial connexin (Cx)40 and Cx43 mRNA and protein expression levels, but produced Cx43 dephosphorylation, increased Cx40/Cx43 protein expression ratio and caused Cx43 redistribution toward transverse cell-boundaries. All of the connexin-alterations reversed on CHF recovery, but CHF-induced conduction abnormalities and increased DAF (884±220 seconds, P<0.001 versus control) remained. The atrial fibrous tissue content increased from 3.6±0.7% in control to 14.7±1.5% and 13.3±2.3% in CHF and CHF recovery, respectively (both P<0.01 versus control), with transversely running zones of fibrosis physically separating longitudinally directed muscle bundles. In an ionically based action potential/tissue model, fibrosis was able to account for conduction abnormalities associated with CHF and recovery.

Conclusions: CHF causes atrial connexin changes, but these are not essential for CHF-related conduction disturbances and AF promotion, which are rather related primarily to fibrotic interruption of muscle bundle continuity.


Key words: atrial fibrillation • heart failure • fibrosis • gap junction • connexin